119
Views
12
CrossRef citations to date
0
Altmetric
Magnetic Field Reduces Glucose Level in Diabetic Mice

Daily exposure to inhomogeneous static magnetic field significantly reduces blood glucose level in diabetic mice

, , , , &
Pages 36-45 | Received 27 Oct 2009, Accepted 19 Aug 2010, Published online: 21 Oct 2010

References

  • Antal M, László J. 2009. Exposure to inhomogeneous static magnetic field ceases mechanical allodynia in neuropathic pain. Bioelectromagnetics 30(6):438–445.
  • Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F, Weng JP. 2008. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetologica 45(3):167–178.
  • Bus SA, Maas M, Lindeboom R. 2006. Reproducibility of foot structure measurements in neuropathic diabetic patients using magnetic resonance imaging. Journal of Magnetic Resonance Imaging 24:25–32.
  • Campbell JN, Basbaum AI, Dray A, Dubner A, Dworkin RH, Sang CN, editors. 2006. Emerging strategies for the treatment of neuropathic pain. Seattle, WA: IASP Press. pp 1–514.
  • Chater S, Abdelmelek H, Pequignot JM, Sakly M, Rhouma KB. 2006. Effects of sub-acute exposure to static magnetic field on hematologic and biochemical parameters in pregnant rats. Electromagnetic Biology and Medicine 25(3):135–144.
  • Chebotar'ova LL, Chebotar'ov HIe. 2003. Use of low-power electromagnetic therapy in diabetic polyneuropathy. Rossiiskii fiziologicheskii zhurnal imeni I. M. Sechenova 49(2):85–90.
  • Chen Y. 2002. Magnets on ears helped diabetics. American Journal of Chinese Medicine 30(1):118–185.
  • Chen SR, Khan GM, Pan HL. 2001. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. Anesthesiology 95(4):1007–1012.
  • Colbert AP, Markov SM, Souder JS. 2008. Static magnetic field therapy: Dosimetry considerations. Journal of Alternative and Complementary Medicine 14:577–582.
  • Colbert AP, Wahbeh H, Harling N, Connelly E, Schiffke HC, Forsten C, Gregory WL, Markov MS, Souder JJ, Elmer P, King V. 2007. Static magnetic field therapy: A critical review of treatment parameters. Evidence-based Complementary and Alternative Medicine1–7.
  • Collacott EA, Zimmerman JT, White DW, Rindone JP. 2003. Static magnetic field therapy for symptomatic diabetic neuropathy: A randomized, double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation 84:736–746.
  • Del Seppia C, Luschi P, Ghione S, Crosio E, Choleris E, Papi F. 2000. Exposure to a hypogeomagnetic field or to oscillating magnetic fields similarly reduce stress-induced analgesia in C57 male mice. Life Sciences 66:1299–1306.
  • Del Seppia C, Mezzasalma L, Choleris E, Luschi P, Ghione S. 2003. Effects of magnetic field exposure on open field behaviour and nociceptive responses in mice. Behavioural Brain Research 144:1–9.
  • Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY. 2009. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proceedings of the National Academy of Sciences of the USA 106(33):13998–14003.
  • Harb G, Toreson J, Dufour J, Korbutt G. 2007. Acute exposure to streptozotocin but not human proinflammatory cytokines impairs neonatal porcine islet insulin secretion in vitro but not in vivo. Xenotransplantation 14(6):580–590.
  • Hashish AH, El-Missiry MA, Abdelkader HI, Abou-Saleh RH. 2008. Assessment of biological changes of continuous whole body exposure to static magnetic field and extremely low frequency electromagnetic fields in mice. Ecotoxicology and Environmental Safety 71(3):895–902.
  • High WB, Sikora J, Ugurbil K, Garwood M. 2000. Subchronic in vivo effects of a high static magnetic field (9.4 T) in rats. Journal of Magnetic Resonance Imaging 12(1):122–139.
  • Hunskaar S, Berge OG, Hole K. 1986. A modified hot-plate test sensitive to mild analgesics. Behavioural Brain Research 21(2):101–108.
  • Johnson MS, Ryals JM, Wright DE. 2007. Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice. Journal of Pain 8(8):637–649.
  • Khan GM, Chen SR, Pan HL. 2002. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114(2):291–299.
  • Kamei J, Ohsawa M, Miyata S, Endo K, Hayakawa H. 2008. Effects of cytidine 5′-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice. European Journal of Pharmacology 598(1–3):32–36.
  • Kavaliers M, Ossenkopp KP. 1986. Stress-induced opioid analgesia and activity in mice: inhibitory influences of exposure to magnetic fields. Psychopharmacology 89:440–443.
  • Konermann G, Mönig H. 1986. Effect of static magnetic fields on the prenatal development of the mouse. Radiologe 26(10):490–497.
  • Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, Levitin DJ, Mogil JS. 2006. Social modulation of pain as evidence for empathy in mice. Science 312(5782):1967–1970.
  • Larroque G, Kamba C, Blin D, Lopez FM, Cyteval C. 2006. Imagerie ostéo-articulaire du pied diabétique. Journal of Radiology 87:541–547.
  • László J, Gyires K. 2008. 3 T homogeneous static magnetic field of a clinical MR significantly inhibits pain in mice. Life Sciences 84(1–2):12–17.
  • László J, Reiczigel J, Székely L, Gasparics A, Bogár I, Bors L, Rácz B, Gyires K. 2007. Optimization of static magnetic field parameters improves analgesic effect in mice. Bioelectromagnetics 28:615–627.
  • László J, Tímár J, Gyarmati Zs, Fürst Zs, Gyires K. 2009. Pain-inhibiting inhomogeneous static magnetic field fails to influence locomotor activity and anxiety behaviour in mice: No interference between magnetic field- and morphine-treatment. Brain Research Bulletin 79:316–321.
  • Lin SL, Chang WJ, Lin YS, Ou KL, Lin CT, Lin CP, Huang HM. 2009. Static magnetic field attenuates mortality rate of mice by increasing the production of IL-1 receptor antagonist. International Journal of Radiation Biology 85(7):633–640.
  • Lu L, Zhang Q, Pu LJ, Xu XW, Zhang RY, Zhang JS, Hu J, Yang ZK, Lü AK, Ding FH, Shen J, Chen QJ, Lou S, Fang DH, Shen WF. 2007. Elevation of tumor necrosis factor-α, interleukin-1β and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes. Chinese Medical Journal 120(6):479–484.
  • Okamoto H. 2003. Recent advances in physiological and pathological significance of tryptophan-NAD+ metabolites: Lessons from insulin-producing pancreatic beta-cells. Advances in Experimental Medicine and Biology 527:243–252.
  • Onodera H, Jin Z, Chida S, Suzuki Y, Tago H, Itoyama Y. 2003. Effects of 10-T static magnetic field on human peripheral blood immune cells. Radiation Research 159(6):775–779.
  • Öztaş B, Kalkan T, Tuncel H. 2004. Influence of 50 Hz frequency sinusoidal magnetic field on the blood-brain barrier permeability of diabetic rats. Bioelectromagnetics 25:400–402.
  • Prato FS, Robertson JA, Desjardins D, Hensel J, Thomas AW. 2005. Daily repeated magnetic field shielding induces analgesia in CD-1 mice. Bioelectromagnetics 26:109–117.
  • Rossi S, D'Amico M, Capuano A, Romano M, Petronella P, Di Filippo C. 2006. Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1. Mediators of Inflammation Article ID 60285:1–6.
  • Sándor K, Helyes Zs, Gyires K, Szolcsányi J, László J. 2007. Static magnetic field-induced antinoniceptive effect and the involvement of capsaicin-sensitive sensory nerves in this mechanism. Life Sciences 81:97–102.
  • Seltzer Z, Dubner R, Shir Y. 1990. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Journal of Pain 43(2):205–218.
  • Sindrup SH, Jensen TS. 1999. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Journal of Pain 83:389–400.
  • Szor JK, Holewinski P. 2002. Lessons learned in research: An attempt to study the effects of magnetic therapy. Ostomy Wound Management 48(2):24–29.
  • Tablado L, Soler C, Núñez M, Núñez J, Pérez-Sánchez F. 2000. Development of mouse testis and epididymis following intrauterine exposure to a static magnetic field. Bioelectromagnetics 21(1):19–24.
  • Taniguchi N, Kanai S, Kawamoto M, Endo H, Higashino H. 2004. Study on application of static magnetic field for adjuvant arthritis rats. Evidence-based Complementary and Alternative Medicine 1(2):187–191.
  • Tjolsen A, Rosland JH, Berge OG, Hole K. 1991. The increasing-temperature hot-plate test: An improved test of nociception in mice and rats. Journal of Pharmacological Methods 25(3):241–250.
  • Tsuji Y, Nakagawa M, Suzuki Y. 1996. Five-tesla static magnetic fields suppress food and water consumption and weight gain in mice. Industrial Health 34(4):347–357.
  • Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, Cohen JA, Page JC, Bromberg MB, Schwartz SL, Magnetic Research Group. 2003. Static magnetic field therapy for symptomatic diabetic neuropathy: A randomized, double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation 84(5):736–746.
  • Weintraub MI. 2004. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters − pilot study. Neurorehabilitation and Neural Repair 18(1):42–46.
  • Wróbel MP, Szymborska-Kajanek A, Wystrychowski G, Biniszkiewicz T, Sieroń-Stołtny K, Sieroń A, Pierzchała K, Grzeszczak W, Strojek K. 2008. Impact of low frequency pulsed magnetic fields on pain intensity, quality of life and sleep disturbances in patients with painful diabetic polyneuropathy. Diabetes and Metabolism 34(4 Pt 1):349–354.
  • Yan QC, Tomita N, Ikada Y. 1998. Effects of static magnetic field on bone formation of rat femurs. Medical Engineering and Physics 20(6):397–402.
  • Yang H, Wright JR Jr. 2002. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143(7):2491–2495.
  • Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Journal of Pain 16:109–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.